Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas.
Department of Internal Medicine, Division of Hematology, Hacettepe University Medical School, 00603 Ankara, Turkey, Phone: +90 312 305 15 36 - +90 312 305 15 36 E-mail: dr.songul1978@yahoo.com.
Songül
S
Şerefhanoğlu
Ebru
E
Koca
Hakan
H
Goker
İbrahim Celalettin
İC
Haznedaroğlu
Deniz
D
Çetiner
Nilgün
N
Sayınalp
Yahya
Y
Büyükaşık
Osman İlhami
Oİ
Özcebe